Advertisement
week in cancer news
  • September 15: The Week in Cancer News

    New report charts progress in cancer care, and immediate access to test results can lead to confusion.

    by Eric Fitzsimmons

  • September 8: The Week in Cancer News

    Research shows an increase in late-stage prostate cancer diagnosis, and many non-English speakers don’t make it past helplines to access services.

    by Marci A. Landsmann

  • September 1: The Week in Cancer News

    Regulators reverse course on a plan to limit compensation for breast reconstruction surgery, and a cancer drug is among 10 selected for price negotiations with Medicare to lower costs.

    by Kevin McLaughlin

  • August 25: The Week in Cancer News

    Study finds association between lorazepam use and poorer cancer outcomes, and weight-loss surgery linked to lower cancer risk in women.

    by Thomas Celona

  • August 18: The Week in Cancer News

    Radiation therapy is falling out of favor for some cancer types, and concerns grow about commercially available multi-cancer detection tests.

    by Eric Fitzsimmons

  • August 11: The Week in Cancer News

    Research links testicular cancer in military firefighters to ‘forever chemicals,’ and older women who are screened for breast cancer at risk for overdiagnosis.

    by Marci A. Landsmann

  • August 4: The Week in Cancer News

    Genetic testing can help establish inherited cancer risk, and a new cancer registry tracks breast and prostate cancer in people of African origin.

    by Kevin McLaughlin

  • July 28: The Week in Cancer News

    Less than four minutes of physical activity per day linked to lower cancer risk, and vaccination helped improve outcomes for cancer patients with COVID-19.

    by Thomas Celona

  • July 21: The Week in Cancer News

    ASCO guideline emphasizes the importance of assessment for older cancer patients, and a change in mammogram recommendations reignites screening debates.

    by Eric Fitzsimmons

  • July 14: The Week in Cancer News

    Black men with melanoma have higher risk of dying, and CAR T-cell therapy provides hope for aggressive lymphoma.

    by Marci A. Landsmann